These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28579037)

  • 1. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
    Armstrong LTD; Magnusson MR; Guppy MPB
    J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
    Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
    Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.
    Bourlidou E; Vahtsevanos K; Kyrgidis A; Tilaveridis I; Patsatsi A; Andreadis D; Cheva A; Patrikidou A; Kitikidou K; Boboridis K
    Eur J Dermatol; 2019 Oct; 29(5):490-499. PubMed ID: 31789273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
    Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
    Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
    Kiely JR; Patel AJK
    J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
    van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
    Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
    Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
    J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
    Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
    Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
    Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
    Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular basal cell carcinoma recurrence following surgical treatment: Safe surveillance time.
    Juniat V; Shah P; Vonica O; Daniel CS; Murta F
    Eye (Lond); 2023 Apr; 37(5):971-976. PubMed ID: 35804019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged excision of primary periocular basal cell carcinoma: absence of residual tumour in re-excised specimens: a 10-year series.
    McGrath LA; Meeney A; Currie ZI; Mudhar HS; Tan JH
    Br J Ophthalmol; 2019 Jul; 103(7):976-979. PubMed ID: 30181140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial basal cell carcinoma: analysis of recurrence and follow-up strategies.
    Sartore L; Lancerotto L; Salmaso M; Giatsidis G; Paccagnella O; Alaibac M; Bassetto F
    Oncol Rep; 2011 Dec; 26(6):1423-9. PubMed ID: 21922143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.